Related Experiment Video
Updated: May 24, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Stabilization of ribozyme-like cis-noncoding rRNAs induces apoptotic and nonapoptotic death in lung cells
M Gee1, Y Gu, J R Fields
1Laboratory of Comparative Carcinogenesis, National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Abstract:
Bidirectional non-protein-coding RNAs are ubiquitously transcribed from the genome. Convergent sense and antisense transcripts may regulate each other. Here, we examined the convergent cis-noncoding rRNAs (nc-rRNAs) in A5 and E9 lung cancer models. Sense nc-rRNAs extending from rDNA intergenic region to internal transcribed spacer of around 10 kb in length were identified. nc-rRNAs in sense direction exhibited in vitro characteristics of ribozymes, namely, degradation upon incubation with MgCl(2) and stabilization by complementary oligonucleotides. Detection of endogenous cleavage-ligation products carrying internal deletion of hundreds to thousands nucleotides by massively parallel sequencing confirmed the catalytic properties. Transfection of oligonucleotides pairing with antisense nc-rRNAs stabilized both target and complementary transcripts, perturbed rRNA biogenesis, and induced massive cell death via apoptotic and/or nonapoptotic mechanisms depending on cell type and treatment. Oligonucleotides targeting cellular sense transcripts are less responsive. Spontaneously detached cells, though rare, also showed accumulation of nc-rRNAs and perturbation of rRNA biogenesis. Direct participation of nc-rRNAs in apoptotic and nonapoptotic death was demonstrated by transfection of synthetic nc-rRNAs encompassing the rDNA promoter. In sum, convergent cis-nc-rRNAs follow a feed-forward mechanism to regulate each other and rRNA biogenesis. This opens an opportunity to disrupt rRNA biogenesis, commonly upregulated in cancers, via inhibition of ribozyme-like activities in nc-rRNAs.
Insights
Convergent cis-noncoding RNAs (nc-rRNAs) act as ribozymes, regulating each other and rRNA biogenesis. Inhibiting their catalytic activity offers a novel strategy to disrupt cancer cell proliferation.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Bidirectional non-protein-coding RNAs (nc-rRNAs) are transcribed genome-wide.
- Convergent sense and antisense transcripts potentially regulate each other.
Purpose of the Study:
- Investigate convergent cis-nc-rRNAs in lung cancer models (A5 and E9).
- Characterize the ribozyme-like properties of sense nc-rRNAs.
- Explore the therapeutic potential of targeting nc-rRNAs in cancer.
Main Methods:
- Identification and characterization of sense nc-rRNAs.
- In vitro assays for ribozyme activity (MgCl2 degradation, oligonucleotide stabilization).
- Massively parallel sequencing to detect endogenous cleavage-ligation products.
- Oligonucleotide transfection targeting nc-rRNAs.
- Transfection of synthetic nc-rRNAs.
Main Results:
- Sense nc-rRNAs (~10 kb) were identified, exhibiting ribozyme characteristics.
- Catalytic activity confirmed by detecting internal deletion products.
- Antisense nc-RNA targeting stabilized transcripts, perturbed rRNA biogenesis, and induced cell death.
- Sense transcript targeting showed less response.
- Synthetic nc-RNAs induced cell death, implicating them in apoptosis and non-apoptotic pathways.
- Accumulation of nc-rRNAs and rRNA biogenesis perturbation observed in detached cancer cells.
Conclusions:
- Convergent cis-nc-rRNAs engage in a feed-forward regulatory mechanism impacting rRNA biogenesis.
- nc-rRNAs possess ribozyme-like activities that can be targeted.
- Inhibition of nc-rRNA ribozyme activity presents a potential therapeutic strategy for cancers with upregulated rRNA biogenesis.
Related Concept Videos
Experimental RNAi
RNA Stability
RNA Stability
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...

